Table 3.
Adjusteda odds ratios (aORs) and 95% confidence intervals (CIs) for association of selected chronic conditions and COVID-19-related hospitalizations among Medicare beneficiaries (MBs) with a confirmed COVID-19 illness, USA, January 1–September 30, 2020
| Condition | aOR (95% CI) |
|---|---|
| End-stage renal disease | 2.15 (2.10–2.21) |
| Chronic kidney disease | 1.54 (1.52–1.56) |
| Acute myocardial infarction | 1.45 (1.39–1.53) |
| Heart failure | 1.43 (1.41–1.44) |
| Diabetes | 1.37 (1.36–1.39) |
| Chronic obstructive pulmonary disease | 1.36 (1.34–1.38) |
| Obesity | 1.36 (1.34–1.37) |
| Spina bifida and other congenital anomalies of the nervous system | 1.21 (1.10–1.35) |
| Lung cancer | 1.21 (1.15–1.28) |
| Opioid use disorder | 1.19 (1.15–1.23) |
| Ischemic heart disease | 1.27 (1.25–1.28) |
| Hepatitis | 1.15 (1.11–1.20) |
| Schizophrenia | 1.10 (1.08–1.13) |
| Hypertension | 1.24 (1.22–1.25) |
| Liver disease | 1.18 (1.15–1.21) |
| Atrial fibrillation | 1.18 (1.16–1.20) |
| Cardiovascular diseaseb | 1.24 (1.23–1.26) |
| Anemia | 1.21 (1.20–1.22) |
| Asthma | 1.13 (1.11–1.16) |
| Tobacco | 1.03 (1.01–1.05) |
| Peripheral vascular disease | 1.19 (1.17–1.20) |
| Sickle cell disease | 1.55 (1.31–1.82) |
| Stroke | 1.13 (1.11–1.15) |
| HIV/AIDS | 0.88 (0.82–0.94) |
| Hyperlipidemia | 1.12 (1.11–1.14) |
| Depression | 1.07 (1.06–1.08) |
| Rheumatoid arthritis/osteoarthritis | 1.03 (1.02–1.04) |
| Osteoporosis* | 1.00 (0.98–1.02) |
| Alzheimer disease/dementia* | 1.01 (0.99–1.03) |
aAdjusted for age, sex, race and ethnicity, and urban-rural residence
bAcute myocardial infarction; atrial fibrillation; heart failure; hypertension; ischemic heart disease; stroke/transient ischemic attack; and peripheral vascular disease
*Not significant for Wald chi-square test at P < .05